Sorbitol removal by the metastatic liver: A predictor of systemic toxicity of intra-arterial chemotherapy in patients with liver metastases

Journal of Hepatology

Volumn 30, Issue 6, 1999, Pages 1112-1118

  Bar, Fabrizio ^a   Battista, Stefania ^a   Bucchi, Maria Cesira ^a   Zanon, Claudio ^a   Grosso, Maurizio ^a   Alabiso, Oscar ^a   Miraglia, Stefania ^a   Cappello, Nazario ^a   Gariboldi, Angela ^b   Molino, Gianpaolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Arterio venous shunting; D sorbitol; Floxuridine; Liver metastases; Regional chemotherapy

Indexed keywords

FLOXURIDINE; SORBITOL;

ADULT; AGED; ARTERIOVENOUS SHUNT; ARTICLE; BIOAVAILABILITY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER BLOOD FLOW; LIVER CLEARANCE; LIVER FUNCTION; LIVER METASTASIS; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0033029029     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80267-0     Document Type: Article

References (37)

1. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol. 30:1954;969-985.
2. Ackerman NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery. 75:1974;589-596.
3. Strohmeyer T, Haugeberg G, Lierse W. Angioarchitecture and blood supply of micro- and macrometastases in human livers. An anatomic-pathological investigation using injection-techniques. J Hepatol. 4:1987;181-189.
4. Lin G, Lunderquist A, Hägerstrand I, Boijsen E. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery. 96:(3):1984;517-526.
5. Archer SG, Gray BN. Vascularization of small liver metastases. Br J Surg. 76:1989;545-548.
6. Nott DM, Grime SJ, Yates J, Day DW, Baxter JN, Jenkins SA, et al. Changes in the hepatic perfusion index during the development of experimental hepatic tumors. Br J Surg. 76:1989;259-263.
7. Hemingway DM, Cooke TG, McCurrach G, Bessent RG, Carter R, McKillop JH, et al. Clinical correlation of high activity dynamic hepatic scintigraphy in patients with colorectal cancer. Br J Cancer. 65:1992;781-782.
8. Leen E, Goldberg JA, Anderson JR, Robertson J, Moule B, Cooke TG, et al. Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut. 34:1993;554-557.
9. Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol. 2:1984;498-504.
10. Chen H-SG, Gross JF. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep. 64:1990;31-40.
11. Clarkson B, O'Connor A, Winston L, Hutchison D. The physiologic disposition of 5-fluorouracil and 5-fluoro-2′-deoxyuridine in man. Clin Pharmacol Ther. 5:1965;581-610.
12. Ensminger WD, Rosowsky A, Raso V, Levin DC, Glode M, Come S, et al. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res. 38:1978;3784-3792.
13. Patt YZ, Mavligit GM. Arterial chemotherapy in the management of colorectal cancer: an overview. Semin Oncol. 18:1991;478-490.
14. Sigurdson ER, Ridge JA, Kemeny N, Daly JM. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol. 5:1987;1836-1840.
15. Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escet J, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 10:1992;1112-1118.
16. Chang AE, Schneider PD, Sugerbaker PH. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 206:1987;685-693.
17. Shepard KV, Levin B, Karl RC, Faintuch J, DuBrow RA, Hagle M, et al. Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump. J Clin Oncol. 3:1985;161-169.
18. Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer. 57:1986;465-470.
19. Kemeny N, Selter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, et al. Hepatic arterial FUDR and leucovorin in previously untreated patients with unresectable liver metastases from colorectal cancer. Cancer. 73:1994;1134-1142.
20. Meta-Analysis Group In Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst. 88:1996;252-258.
21. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 334:1994;1255-1260.
22. Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature. Cancer. 78:1996;1639-1645.
23. Sugano S, Miyoshi K, Suzuki T, Kawafune T, Kubota M. Intrahepatic arteriovenous shunting due to hepatocellular carcinoma and cirrhosis, and its change by transcatheter arterial embolization. Am J Gastroenterol. 89:1994;184-188.
24. Kaplan WD, Come SE, Takvorian RW, Laffin SM, Gelman RS, Weiss GR, et al. Pulmonary uptake of Technetium 99m macroag-gregated albumin: a predictor of gastrointestinal toxicity during hepatic artery perfusion. J Clin Oncol. 2:1984;1266-1269.
25. Huet P-M, Pomier-Layrargues G, Villeneuve J-P, Varin F, Viallet A. Intrahepatic circulation in liver disease. Semin Liver Dis. 6:1986;277-286.
26. Molino G, Cavanna A, Avagnina P, Ballaré M, Torchio M. Hepatic clearance of D-sorbitol: noninvasive test for evaluating functional liver plasma flow. Dig Dis Sci. 32:1987;753-758.
27. Molino G, Avagnina P, Ballaré M, Torchio M, Niro AG, Aurucci PE, et al. Combined evaluation of total and functional liver plasma flows and intrahepatic shunting. Dig Dis Sci. 36:1991;1189-1196.
28. Molino G, Battista S, Bar F, Garello E, Avagnina P, Grosso M, et al. Determination of functional portal-systemic shunting in patients submitted to hepatic angiography. Liver. 16:1996;347-352.
29. Molino G, Bar F, Battista S, Torchio M, Niro AG, Garello E, et al. Arterial-venous shunting in liver cirrhosis. Dig Dis Sci. 43:1998;51-55.
30. Molino G, Avagnina P, Belforte G, Bircher J. Assessment of the hepatic circulation in humans: new concepts based on evidence derived from a D-sorbitol clearance method. J Lab Clin Med. 131:1998;393-405.
31. Zanon C, Grosso M, Zanon E, Veltri A, Alabiso O, Bazzan M, et al. Transaxillary access to effect regional chemotherapy with hepatic artery infusion (HAI) for secondary or primitive hepatic tumors. [abstract] Eur J Surg Oncol. 22:1996;448.
32. Zanon C, Grosso M. Transaxillary access to perform hepatic artery infusion (HAI) for secondary or primitive hepatic tumours. Eur J Cancer. 32A:1996;1824-1825.
33. Bergmeyer HU, Gruber W, Gutman I. D-sorbitol. Bergmeyer HU, . Methods of Enzymatic Analysis. 1975;1323-1330 Verlag Chemie Weinheim and Academic Press, New York and London.
34. Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone vs fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer. 69:1992;327-334.
35. WHO Handbook for Reporting Results of Cancer Treatment . Geneva. 48:1979.
36. Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, et al. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology. 95:1986;749-759.
37. Gerlach U, Hiby W. Sorbitol dehydrogenase. Bergmeyer HU, . Methods of Enzymatic Analysis. 1975;569 Verlag Chemie Weinheim and Academic Press, New York and London.